000 01849nam  2200337zi 4500
0019.887809
003CaOODSP
00520221107171818
006m     o  d f      
007cr |||||||||||
008200528t20202020onc     o    f00| 0 eng d
020 |a9780660350585
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH134-16/2020E-PDF
24500|aCannabis adverse reaction reporting guide : |badverse reaction reporting guidance for licence holders under the cannabis regulations.
264 1|a[Ottawa] : |bGovernment of Canada = Gouvernement du Canada, |c2020.
264 4|c©2020
300 |a1 online resource (30 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Guide sur la déclaration des effets indésirables du cannabis : document d’orientation relatif à la déclaration des effets indésirables à l’intention des titulaires de licences en vertu du règlement sur le cannabis.
500 |aIssued also in HTML format.
520 |a"This guide describes Health Canada's expectations pertaining to adverse reaction reporting including the form and manner for submitting adverse reaction reports and the information that should be included in these reports"--page 5.
650 0|aCannabis|xSide effects|xReporting|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tGuide sur la déclaration des effets indésirables du cannabis : |w(CaOODSP)9.887811
85640|qPDF|s1.61 MB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/H134-16-2020-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/publications/drugs-health-products/cannabis-adverse-reaction-reporting-licence-holders.html